DNA Sequencing Market

DNA Sequencing Market is valued at USD 4581.2 Million in 2020 and expected to reach USD 10944.1 Million by 2027 with the CAGR of 11.5% over the forecast period. Growing adoption of DNA sequencing systems and application of DNA sequencing in clinical diagnosis and drug discovery are the major factors driving the growth of Global DNA Sequencing Market.

Scope of Global DNA Sequencing Market Report:

DNA sequencing is a laboratory method that is used to establish the precise sequence of bases such as adenine, guanine, cytosine, and thymine in a DNA molecule. DNA sequencing is a technology where numerous DNA strands can be sequenced via massive parallelization. This sequencing contains both non-Sanger’s methods of sequencing and Sanger’s method of sequencing. It is a method of deciding the nucleic acid sequence in the order of nucleotides in DNA. The DNA base sequence holds the data a cell requires to gather protein and RNA molecules. DNA sequence data is essential to scientists for examining the roles of genes.

This technique includes various advantages such as high accuracy & speed, low cost, and accurate findings even from minimal sample input are presented by DNA sequencing over microarray and more genomic analysis processes. DNA sequencing is utilized to implement numerous applications such as oncology studies, biomarker discovery, forensics, personalized medicine, and others. It has simplified nucleotide analysis and involves generally substituted conventional tools of genomics, especially genotyping, microarray, and others. Fredrick Sanger hypothesized the first approach for sequencing the DNA, in the year 1977, identified as a chain termination method.

The Global DNA Sequencing Market is segmented on the basis on product, application, technology, end-user, and region & country level. Based on product, the DNA sequencing market is classified as consumable, instrument, and service. Based on application, the market is categorized as diagnostics, biomarkers & cancer, reproductive health, personalized medicine, forensics, and other. Based on technology, the DNA sequencing market is classified as sequencing by synthesis, ion semiconductor sequencing, sequencing by ligation, pyrosequencing, single-molecule real-time sequencing, chain termination sequencing, nanopore sequencing. Based on end-user, the DNA sequencing market is classified as academic & government research institutes, pharmaceutical companies, biotechnology companies, and hospitals & clinics.

Report Analysis	Details
Historical data	2018 - 2021
Forecast Period	2022 - 2028
Market Size in 2020:	USD 4581.2 Million
Base year considered	2021
Forecast Period CAGR %:	11.5%
Market Size Expected in 2027:	USD 10944.1 Million
Tables, Charts & Figures:	175
Pages	200
Key Players/Companies	Perkin Elmer, Roche Holdings AG, Siemens AG, Illumina, Agilent Technologies Inc., Genia Corporation, Oxford Nanopore technologies, Koninklijke Philips N.V., Pacific Biosciences, Johnson & Johnson, Deep Genomics, Inc., Life Technologies, Illumina, Eppendorf, Tecan, Thermo Scientific, Hamilton Thorne Biosciences, General Electric Company, Siemens Healthineers GmbH, Myriad Genetics, Bayer Corporation, Beckman Coulter, and others.
Segments Covered	By Technolgy, By Product, By End User, By Application
Regional Analysis	North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa

Global DNA Sequencing Market Segmentation:

By Product:

• Consumable
• Instrument
• Service

By Application:

• Diagnostics
• Biomarkers & Cancer
• Reproductive Health
• Personalized Medicine
• Forensics, and Other

By Technology:

• Sequencing by Synthesis
• Ion Semiconductor Sequencing
• Sequencing by Ligation
• Pyrosequencing
• Single-molecule Real-time Sequencing
• Chain Termination Sequencing
• Nanopore Sequencing

By End-User:

• Academic & Government Research Institutes
• Pharmaceutical Companies
• Biotechnology Companies
• Hospitals & Clinics

DNA Sequencing Market Key Players:

• Perkin Elmer
• Roche Holdings AG
• Siemens AG
• Illumina
• Agilent Technologies Inc.
• Genia Corporation
• Oxford Nanopore technologies
• Koninklijke Philips N.V.
• Pacific Biosciences
• Johnson & Johnson
• Deep GenomicsInc.
• Life Technologies
• Illumina
• Eppendorf
• Tecan
• Thermo Scientific
• Hamilton Thorne Biosciences
• General Electric Company
• Siemens Healthineers GmbH
• Myriad Genetics
• Bayer Corporation
• Beckman Coulter
• Others.

News: World’s First Mobile Genome Sequence Analyzer Developed

December 8^th, 2020- Researchers at Cold Spring Harbor Laboratory (CSHL) say they have developed the world’s first mobile genome sequence analyzer, a new iPhone app called iGenomics. By pairing an iPhone with a handheld DNA sequencer, users can create a mobile genetics laboratory, reminiscent of the “tricorder” featured in Star Trek. The iGenomics app runs entirely on the iOS device, reducing the need for laptops or large equipment in the field, which is useful for pandemic and ecology workers, noted the scientists. The iPhone app was developed to complement the tiny DNA sequencing devices being made by Oxford Nanopore. Users can AirDrop sequencing data to each other, enabling DNA analysis in remote locations even those without internet access.

Global DNA Sequencing Market Dynamics:

The growing adoption of DNA Sequencing systems all over the world is one of the prominent factors contributing to the growth of the DNA Sequencing market during the forecast period. DNA sequencing has produced a paradigm change in proteomic and genomic research as it is an extremely precise and high-throughput technology that is applied for a range of applications, such as WGS, de novo assembly, and DNA resequencing. For instance; Illumina, an American company has installed NovaSeq 6000 Sequencing System at the Whitehead Institute for Biomedical Research, Massachusetts, the U.S., in June 2020. Also, professors Shankar Balasubramanian and David Klenerman had innovated Next Generation DNA Sequencing technology in 2020.

In addition, increasing application of DNA sequencing in clinical diagnosis and drug discovery is another factor likely to boost the DNA sequencing market growth. DNA sequencing technology retains significant potential in clinical research and the development of cancer diagnostics and therapeutics. Furthermore, increasing research and development in this field is also one of the major factors expected to foster the market growth. For instance; according to the Hong-Yan Liu et al. research article issued in Scientific Reports Journal 2019, it has been anticipated that 80% of rare diseases are genomic in origin, and thus, genome sequencing-based diagnosis presents a promising substitute for rare-disease management. This is projected to have a positive impact on the market studied.

However, ethical & legal limitations and accuracy & standardization concerns associated with DNA sequencing may limit the growth  of global DNA sequencing market. In spite of that, strategic projects undertaken by international organizations to develop their presence owing to the high customer base are likely to create an opportunity for the further growth of the global DNA sequencing market. 

Global DNA Sequencing Market Regional Analysis:

On geographic basis, North America is expected to dominate the growth of the DNA sequencing market owing to various causes such as high investment in R&D, and availability of technologically advanced healthcare infrastructure, and many more. The increasing supportive government initiatives in the U.S. and Canada that endorses research in drug development and treatment of cancer is a leading factor fostering the growth of global DNA sequencing market in this region.

The Asia Pacific is predicted to witness a beneficial growth in the global DNA sequencing market during the forecast period owing to the factors such as growing investment in this field in this region. Strategic projects undertaken by international corporations is one of the major factors fueling the growth of the market positively. For instance, a California-based firm, GenapSys, increased USD 75 million to finance the global expansion of its tabletop DNA sequences in February 2020 to boost the control of coronavirus in the region.

On Special Requirement DNA Sequencing Market Report is also available for below Regions and Country:

North America

• U.S.
• Canada

Europe

• Germany
• France
• U.K.
• Italy
• Spain
• Sweden
• Netherland
• Turkey
• Switzerland
• Belgium
• Rest of Europe

Asia-Pacific

• South Korea
• Japan
• China
• India
• Australia
• Philippines
• Singapore
• Malaysia
• Thailand
• Indonesia
• Rest Of APAC

Latin America

• Mexico
• Colombia
• Brazil
• Argentina
• Peru
• Rest of South America

Middle East and Africa

• Saudi Arabia
• UAE
• Egypt
• South Africa
• Rest Of MEA

Key Benefits for Global DNA Sequencing Market Report:

• Global DNA Sequencing Market Trends report covers in depth historical and forecast analysis.
• Global DNA Sequencing Market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.
• Global DNA Sequencing Market trends report helps to identify opportunities in marketplace.
• Global DNA Sequencing Market report covers extensive analysis of emerging trends and competitive landscape.